Miek C. Jong

1.6k total citations
17 papers, 1.3k citations indexed

About

Miek C. Jong is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Miek C. Jong has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Physiology. Recurrent topics in Miek C. Jong's work include Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers), Cholesterol and Lipid Metabolism (6 papers) and Lipid metabolism and disorders (5 papers). Miek C. Jong is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers), Cholesterol and Lipid Metabolism (6 papers) and Lipid metabolism and disorders (5 papers). Miek C. Jong collaborates with scholars based in Netherlands, United States and Austria. Miek C. Jong's co-authors include Louis M. Havekes, Marten H. Hofker, Vivian E.H. Dahlmans, Peter J. Voshol, Patrick C.N. Rensen, Hans van der Boom, Theo J.C. van Berkel, Johannes A. Romijn, Ko Willems van Dijk and Marion J. Gijbels and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Diabetes.

In The Last Decade

Miek C. Jong

17 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miek C. Jong Netherlands 15 477 462 451 365 280 17 1.3k
A. Fredenrich France 17 721 1.5× 418 0.9× 553 1.2× 292 0.8× 520 1.9× 39 1.6k
Graham F. Maguire Canada 24 376 0.8× 543 1.2× 586 1.3× 386 1.1× 122 0.4× 41 1.8k
D Pometta Switzerland 21 358 0.8× 738 1.6× 560 1.2× 297 0.8× 212 0.8× 77 1.9k
Xian-Cheng Jiang United States 17 840 1.8× 300 0.6× 497 1.1× 375 1.0× 372 1.3× 22 1.6k
Dawn Marchadier United States 18 465 1.0× 852 1.8× 537 1.2× 700 1.9× 139 0.5× 20 1.6k
R Ramakrishnan United States 13 455 1.0× 803 1.7× 837 1.9× 502 1.4× 167 0.6× 20 1.5k
Sanni Söderlund Finland 23 333 0.7× 818 1.8× 472 1.0× 418 1.1× 235 0.8× 47 1.4k
Anna Montali Italy 23 325 0.7× 532 1.2× 561 1.2× 545 1.5× 93 0.3× 50 1.5k
Anne Minnich United States 20 1.1k 2.3× 433 0.9× 834 1.8× 207 0.6× 360 1.3× 34 2.1k
Yuko Kako United States 22 871 1.8× 573 1.2× 437 1.0× 710 1.9× 591 2.1× 28 2.1k

Countries citing papers authored by Miek C. Jong

Since Specialization
Citations

This map shows the geographic impact of Miek C. Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miek C. Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miek C. Jong more than expected).

Fields of papers citing papers by Miek C. Jong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miek C. Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miek C. Jong. The network helps show where Miek C. Jong may publish in the future.

Co-authorship network of co-authors of Miek C. Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Miek C. Jong. A scholar is included among the top collaborators of Miek C. Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miek C. Jong. Miek C. Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Westerterp, Marit, Jimmy F.P. Berbée, Dianne J. Delsing, et al.. (2007). Apolipoprotein C-I binds free fatty acids and reduces their intracellular esterification. Journal of Lipid Research. 48(6). 1353–1361. 26 indexed citations
2.
Muurling, Martin, Miek C. Jong, Ronald P. Mensink, et al.. (2002). A low-fat diet has a higher potential than energy restriction to improve high-fat diet-induced insulin resistance in mice. Metabolism. 51(6). 695–701. 38 indexed citations
3.
Gautier, Thomas, David Masson, Miek C. Jong, et al.. (2002). Apolipoprotein CI Deficiency Markedly Augments Plasma Lipoprotein Changes Mediated by Human Cholesteryl Ester Transfer Protein (CETP) in CETP Transgenic/ApoCI-knocked Out Mice. Journal of Biological Chemistry. 277(35). 31354–31363. 46 indexed citations
4.
5.
Goudriaan, Jeltje R., Paul J. Tacken, Vivian E.H. Dahlmans, et al.. (2001). Protection From Obesity in Mice Lacking the VLDL Receptor. Arteriosclerosis Thrombosis and Vascular Biology. 21(9). 1488–1493. 107 indexed citations
6.
Jong, Miek C., Patrick C.N. Rensen, Vivian E.H. Dahlmans, et al.. (2001). Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice. Journal of Lipid Research. 42(10). 1578–1585. 124 indexed citations
7.
Jong, Miek C., Peter J. Voshol, Martin Muurling, et al.. (2001). Protection From Obesity and Insulin Resistance in Mice Overexpressing Human Apolipoprotein C1. Diabetes. 50(12). 2779–2785. 83 indexed citations
8.
Mensenkamp, Arjen R., Marja J.A. van Luyn, Harry van Goor, et al.. (2000). Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice. Journal of Hepatology. 33(2). 189–198. 24 indexed citations
9.
Zhu, Yiwen, Miek C. Jong, Kelly A. Frazer, et al.. (2000). Genomic interval engineering of mice identifies a novel modulator of triglyceride production. Proceedings of the National Academy of Sciences. 97(3). 1137–1142. 36 indexed citations
10.
Rensen, Patrick C.N., Miek C. Jong, Hans van der Boom, et al.. (2000). Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo. Journal of Biological Chemistry. 275(12). 8564–8571. 66 indexed citations
11.
Dijk, Ko Willems van, Miek C. Jong, André van der Zee, et al.. (2000). Apolipoprotein E2 (Lys146→Gln) Causes Hypertriglyceridemia due to an Apolipoprotein E Variant–Specific Inhibition of Lipolysis of Very Low Density Lipoproteins–Triglycerides. Arteriosclerosis Thrombosis and Vascular Biology. 20(7). 1800–1806. 11 indexed citations
12.
Post, Sabine M., Baukje de Roos, Martijn Vermeulen, et al.. (2000). Cafestol Increases Serum Cholesterol Levels in Apolipoprotein E*3-Leiden Transgenic Mice by Suppression of Bile Acid Synthesis. Arteriosclerosis Thrombosis and Vascular Biology. 20(6). 1551–1556. 40 indexed citations
13.
Jong, Miek C., et al.. (2000). Oxidized VLDL Induces Less Triglyceride Accumulation in J774 Macrophages Than Native VLDL Due to an Impaired Extracellular Lipolysis. Arteriosclerosis Thrombosis and Vascular Biology. 20(1). 144–151. 29 indexed citations
14.
Mensenkamp, Arjen R., Miek C. Jong, Harry van Goor, et al.. (1999). Apolipoprotein E Participates in the Regulation of Very Low Density Lipoprotein-Triglyceride Secretion by the Liver. Journal of Biological Chemistry. 274(50). 35711–35718. 110 indexed citations
15.
Jong, Miek C., Marten H. Hofker, & Louis M. Havekes. (1999). Role of ApoCs in Lipoprotein Metabolism. Arteriosclerosis Thrombosis and Vascular Biology. 19(3). 472–484. 430 indexed citations
16.
Jong, Miek C., Vivian E.H. Dahlmans, P. Hans, Marten H. Hofker, & Louis M. Havekes. (1998). Effects of fenofibrate on hyperlipidemia and postprandial triglyceride metabolism in human apolipoprotein C1 transgenic mice. Atherosclerosis. 141. S77–S80. 1 indexed citations
17.
Jong, Miek C., Vivian E.H. Dahlmans, Patrick J. van Gorp, et al.. (1996). Both Lipolysis and Hepatic Uptake of VLDL Are Impaired in Transgenic Mice Coexpressing Human Apolipoprotein E*3Leiden and Human Apolipoprotein C1. Arteriosclerosis Thrombosis and Vascular Biology. 16(8). 934–940. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026